IRTC

In a report released today, Marie Thibault from BTIG reiterated a Buy rating on Irhythm Technologies (IRTC – Research Report), with a price target of $155.00. The company's shares closed last Thursday at $115.07. According to TipRanks.com, Thibault is a 4-star analyst with an average return of 5.1% and a 27.7% success rate. Thibault covers the Healthcare sector, focusing on stocks such as Establishment Labs Holdings, Edwards Lifesciences, and Pear Therapeutics. The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Irhythm Technologies with a $154.14 average price target, a 39.4% upside from current levels. In a report issued on June 22, J.P.
https://www.tipranks.com/news/blurbs/irhythm-technologies-irtc-receives-a-buy-from-btig-2?utm_source=advfn.com&utm_medium=referral